Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.
Researchers conducted a study to determine whether molecular biomarkers of tubular injury measured on hospital admission are a significant predictor of acute kidney injury in patients with SARS-CoV-2 infection.
Investigators evaluated resistance to fluoroquinolones, nitrofurantoin, and trimethoprim-sulfamethoxazole in patients with uncomplicated urinary tract infection.
Investigators determined whether ABO and Rh blood groups were associated with risk for SARS-CoV-2 infection and severe COVID-19 illness.
Study authors provided a systemic analysis of to identify key characteristics of extensive and advanced COVID-19.
